Protein Carbonylation and Lipid Peroxidation in Hematological Malignancies

Changes in Serum Interleukin-8 and sRAGE Levels in Multiple Myeloma Patients

(2020) ALESSANDRO ALLEGRA et al.   ANTICANCER RESEARCH

Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties

(2020) Ravi K. Anchoori et al.   PLoS One

Cellular Aging Characteristics and Their Association with Age-Related Disorders

(2020) Magdalena Rudzińska et al.   Antioxidants

Acute lymphoblastic leukaemia

(2020) Florent Malard et al.   LANCET

Chronic Lymphocytic Leukaemia in 2020: the Future Has Arrived

(2020) Kate Milne et al.   Current Oncology Reports

Iron Causes Lipid Oxidation and Inhibits Proteasome Function in Multiple Myeloma Cells: A Proof of Concept for Novel Combination Therapies

(2020) Jessica Bordini et al.   Cancers

Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib

(2020) Giuseppina Camiolo et al.   Redox Biology

Improved survival outcomes and restoration of graft-vs-leukemia effect by deferasirox after allogeneic stem cell transplantation in acute myeloid leukemia

(2019) Byung-Sik Cho et al.   Cancer Medicine

Blast Transformation in Myeloproliferative Neoplasms: Risk Factors, Biological Findings, and Targeted Therapeutic Options

(2019) Alessandra Iurlo et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Iron chelation and 2‐oxoglutarate‐dependent dioxygenase inhibition suppress mantle cell lymphoma's cyclin D1

(2019) Olga Babosova et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis

(2019) Heinz Läubli et al.   Frontiers in Immunology

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

(2019) Frank Weinberg et al.   Cancers

Sustain, Adapt, and Overcome—Hypoxia Associated Changes in the Progression of Lymphatic Neoplasia

(2019) Orsolya Matolay et al.   Frontiers in Oncology

Protein Carbonylation in Patients with Myelodysplastic Syndrome: An Opportunity for Deferasirox Therapy

(2019) Alba Rodríguez-García et al.   Antioxidants

What Does Chronic Myeloid Leukaemia Tell Us About Other Leukaemias?

(2019) Robert Peter Gale et al.   Current Hematologic Malignancy Reports

Anticancer activity of a Gold(I) phosphine thioredoxin reductase inhibitor in multiple myeloma

(2019) Jun Hui Sze et al.   Redox Biology

Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management

(2018) Stephen M. Ansell   AMERICAN JOURNAL OF HEMATOLOGY

Mechanisms of platelet clearance and translation to improve platelet storage

(2018) M. Edward Quach et al.   BLOOD

Rationale for assessing the therapeutic potential of resveratrol in hematological malignancies

(2018) J. Luis Espinoza et al.   BLOOD REVIEWS

Inhibition of thioredoxin activates mitophagy and overcomes adaptive bortezomib resistance in multiple myeloma

(2018) Zhihong Zheng et al.   Journal of Hematology & Oncology

Melatonin and Cancer Hallmarks

(2018) Wamidh Talib   MOLECULES

Role of hypoxia in Diffuse Large B-cell Lymphoma: Metabolic repression and selective translation of HK2 facilitates development of DLBCL

(2018) Kavita Bhalla et al.   Scientific Reports

Potential protective effects of the edible algae Arthrospira platensis against lead-induced oxidative stress, anemia, kidney variables and histopathological changes in adult rats

(2018) Manel GARGOURI et al.   Applied Physiology Nutrition and Metabolism

Acute myeloid leukaemia

(2018) Nicholas J Short et al.   LANCET

Proteomic approach for understanding milder neurotoxicity of Carfilzomib against Bortezomib

(2018) Betul Karademir et al.   Scientific Reports

Deferasirox selectively induces cell death in the clinically relevant population of leukemic CD34+CD38– cells through iron chelation, induction of ROS, and inhibition of HIF1α expression

(2018) Saar Shapira et al.   EXPERIMENTAL HEMATOLOGY

Activation of RAGE/STAT3 pathway by methylglyoxal contributes to spinal central sensitization and persistent pain induced by bortezomib

(2017) Jia-You Wei et al.   EXPERIMENTAL NEUROLOGY

Enhanced plasma protein carbonylation in patients with myelodysplastic syndromes

(2017) Alžběta Hlaváčková et al.   FREE RADICAL BIOLOGY AND MEDICINE

The Essential Medicinal Chemistry of Curcumin

(2017) Kathryn M. Nelson et al.   JOURNAL OF MEDICINAL CHEMISTRY

Non-Hodgkin lymphoma

(2017) James O Armitage et al.   LANCET

Nucleotide excision repair is a potential therapeutic target in multiple myeloma

(2017) R Szalat et al.   LEUKEMIA

Advanced glycation endproducts (AGEs) in saliva of patients with multiple myeloma – a pilot study

(2017) Joseph Katz et al.   LEUKEMIA & LYMPHOMA

Thioredoxin-1, chemokine (C-X-C motif) ligand-9 and interferon-γ expression in the neoplastic cells and macrophages of Hodgkin lymphoma: clinicopathologic correlations and potential prognostic implications

(2017) Theodoros P. Vassilakopoulos et al.   LEUKEMIA & LYMPHOMA

Myeloproliferative Neoplasms

(2017) Jerry L. Spivak   NEW ENGLAND JOURNAL OF MEDICINE

Targeting the Thioredoxin System for Cancer Therapy

(2017) Junmin Zhang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Synergistic inhibitory effects of deferasirox in combination with decitabine on leukemia cell lines SKM-1, THP-1, and K-562

(2017) Nianyi Li et al.   Oncotarget

The hypoxia signalling pathway in haematological malignancies

(2017) Marta Irigoyen et al.   Oncotarget

Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: Oxidative eustress

(2017) Helmut Sies   Redox Biology

Reactive oxygen species in BCR-ABL1-expressing cells - relevance to chronic myeloid leukemia

(2016) Joanna Antoszewska-Smith et al.   ACTA BIOCHIMICA POLONICA

TrxR1 inhibition overcomes both hypoxia-induced and acquired bortezomib resistance in multiple myeloma through NF-кβ inhibition

(2016) Prahlad V. Raninga et al.   CELL CYCLE

Cu(II)-coumestrol interaction leads to ROS-mediated DNA damage and cell death: a putative mechanism for anticancer activity

(2016) Atif Zafar et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Iron chelation: an adjuvant therapy to target metabolism, growth and survival of murine PTEN-deficient T lymphoma and human T lymphoblastic leukemia/lymphoma

(2016) Joy Benadiba et al.   LEUKEMIA & LYMPHOMA

Assessment of oxidative/nitrative modifications of plasma proteins, selected ROTEM parameters and kinetics of fibrinogen polymerization in patients with multiple myeloma at diagnosis

(2016) W. Nowak et al.   MEDICAL ONCOLOGY

Diagnostic and predictive biomarkers for lymphoma diagnosis and treatment in the era of precision medicine

(2016) Ruifang Sun et al.   MODERN PATHOLOGY

Prophylactic role ofEnhydra fluctuansagainst arsenic-induced hepatotoxicity via anti-apoptotic and antioxidant mechanisms

(2016) Tarun K. Dua et al.   REDOX REPORT

Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats

(2016) Faisal Imam et al.   TOXICOLOGY MECHANISMS AND METHODS

Reed-Sternberg cells in Hodgkin’s lymphoma present features of cellular senescence

(2016) J Gopas et al.   Cell Death & Disease

The iron chelator deferasirox induces apoptosis by targeting oncogenic Pyk2/β-catenin signaling in human multiple myeloma

(2016) Yusuke Kamihara et al.   Oncotarget

Cannabinoids synergize with carfilzomib, reducing multiple myeloma cells viability and migration

(2016) Massimo Nabissi et al.   Oncotarget

Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism

(2016) Zuzana Rychtarcikova et al.   Oncotarget

Apremilast reversed carfilzomib-induced cardiotoxicity through inhibition of oxidative stress, NF-κB and MAPK signaling in rats

(2016) Faisal Imam et al.   TOXICOLOGY MECHANISMS AND METHODS

Effect of combined deferasirox and 5-azacytidine treatment on human leukemia cells in vitro

(2015) Satoshi Imanishi et al.   ANNALS OF HEMATOLOGY

The iron chelator deferasirox affects redox signalling in haematopoietic stem/progenitor cells

(2015) Tiziana Tataranni et al.   BRITISH JOURNAL OF HAEMATOLOGY

Chemistry and Biology of Resveratrol-Derived Natural Products

(2015) Mitchell H. Keylor et al.   CHEMICAL REVIEWS

Oxidative stress levels are correlated with P15 and P16 gene promoter methylation in myelodysplastic syndrome patients

(2015) Ana Cristina Gonçalves et al.   CLINICAL AND EXPERIMENTAL MEDICINE

A natural xanthone increases catalase activity but decreases NF-kappa B and lipid peroxidation in U-937 and HepG2 cell lines

(2015) Binay K. Sahoo et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Oxidative Stress, Bone Marrow Failure, and Genome Instability in Hematopoietic Stem Cells

(2015) Christine Richardson et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Mitochondrial thioredoxin reductase regulates major cytotoxicity pathways of proteasome inhibitors in multiple myeloma cells

(2015) E E Fink et al.   LEUKEMIA

Acute Lymphoblastic Leukemia in Children

(2015) Stephen P. Hunger et al.   NEW ENGLAND JOURNAL OF MEDICINE

Molecular characterization of the boron adducts of the proteasome inhibitor bortezomib with epigallocatechin-3-gallate and related polyphenols

(2015) Stephen J. Glynn et al.   ORGANIC & BIOMOLECULAR CHEMISTRY

Oxidative stress in dogs with multicentric lymphoma: Effect of chemotherapy on oxidative and antioxidant biomarkers

(2015) Nathieli B. Bottari et al.   REDOX REPORT

Inhibition of thioredoxin 1 leads to apoptosis in drug-resistant multiple myeloma

(2015) Prahlad V. Raninga et al.   Oncotarget

Molecular mechanisms of cisplatin cytotoxicity in acute promyelocytic leukemia cells

(2015) Sanjay Kumar et al.   Oncotarget

Targeting cancer by binding iron: Dissecting cellular signaling pathways

(2015) Goldie Y.L. Lui et al.   Oncotarget

HFE gene mutation and oxidative damage biomarkers in patients with myelodysplastic syndromes and its relation to transfusional iron overload: an observational cross-sectional study

(2015) G. F. De Souza et al.   BMJ Open

Deferasirox therapy is associated with reduced mortality risk in a medicare population with myelodysplastic syndromes

(2015) Amer M Zeidan et al.   Journal of Comparative Effectiveness Research

ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice

(2015) Xiao Chai et al.   Scientific Reports

Resveratrol increases the bone marrow hematopoietic stem and progenitor cell capacity

(2014) Pauline Rimmelé et al.   AMERICAN JOURNAL OF HEMATOLOGY

Impact of iron overload and potential benefit from iron chelation in low-risk myelodysplastic syndrome

(2014) N. Shenoy et al.   BLOOD

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

(2014) A. Tefferi et al.   BLOOD

Deferasirox for transfusion-dependent patients with myelodysplastic syndromes: safety, efficacy, and beyond (GIMEMA MDS0306 Trial)

(2014) Emanuele Angelucci et al.   EUROPEAN JOURNAL OF HAEMATOLOGY

Toward resolving the unsettled role of iron chelation therapy in myelodysplastic syndromes

(2014) Drorit G Merkel et al.   Expert Review of Anticancer Therapy

Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas

(2014) Hamid Bur et al.   HISTOPATHOLOGY

Arsenic trioxide induces oxidative stress, DNA damage, and mitochondrial pathway of apoptosis in human leukemia (HL-60) cells

(2014) Sanjay Kumar et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Melatonin: a well-documented antioxidant with conditional pro-oxidant actions

(2014) Hong-Mei Zhang et al.   JOURNAL OF PINEAL RESEARCH

Molecular damage caused by generation of reactive oxygen species in the redox cycle of doxorubicin–transferrin conjugate in human leukemia cell lines

(2014) Marzena Szwed et al.   LEUKEMIA & LYMPHOMA

Precision therapy for lymphoma—current state and future directions

(2014) Andrew M. Intlekofer et al.   Nature Reviews Clinical Oncology

Plasma Levels of Aminothiols, Nitrite, Nitrate, and Malondialdehyde in Myelodysplastic Syndromes in the Context of Clinical Outcomes and as a Consequence of Iron Overload

(2014) Kristýna Pimková et al.   Oxidative Medicine and Cellular Longevity

Anticancer activity ofCocculus hirsutusagainst Dalton’s lymphoma ascites (DLA) cells in mice

(2014) B. Samuel Thavamani et al.   PHARMACEUTICAL BIOLOGY

Doxorubicin-induced carbonylation and degradation of cardiac myosin binding protein C promote cardiotoxicity

(2014) Baikuntha Aryal et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Increased Oxidative Damage Associated with Unfavorable Cytogenetic Subgroups in Chronic Lymphocytic Leukemia

(2014) Rosa Collado et al.   Biomed Research International

Investigation of the Antioxidant Status in Multiple Myeloma Patients: Effects of Therapy

(2013) Wesen A. Mehdi et al.   Asian Pacific Journal of Cancer Prevention

Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet

(2013) L. Malcovati et al.   BLOOD

Deferasirox shows in vitro and in vivo antileukemic effects on murine leukemic cell lines regardless of iron status

(2013) Dae-Hyoung Lee et al.   EXPERIMENTAL HEMATOLOGY

Molecular mechanisms of the pro-apoptotic actions of melatonin in cancer: a review

(2013) Mariano Bizzarri et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Increased parameters of oxidative stress and its relation to transfusion iron overload in patients with myelodysplastic syndromes

(2013) Geane Felix de Souza et al.   JOURNAL OF CLINICAL PATHOLOGY

Oxidative stress leads to increased mutation frequency in a murine model of myelodysplastic syndrome

(2013) Yang Jo Chung et al.   LEUKEMIA RESEARCH

Protein carbonylation as a major hallmark of oxidative damage: Update of analytical strategies

(2013) Maria Fedorova et al.   MASS SPECTROMETRY REVIEWS

Diffuse large B-cell lymphoma—treatment approaches in the molecular era

(2013) Mark Roschewski et al.   Nature Reviews Clinical Oncology

Resveratrol Induces Cell Cycle Arrest and Apoptosis in Malignant NK Cells via JAK2/STAT3 Pathway Inhibition

(2013) Ly Quoc Trung et al.   PLoS One

Oxidative stress in oncohematologic diseases: an update

(2013) Selene Imbesi et al.   Expert Review of Hematology

Protective effects of antioxidants on deoxynivalenol-induced damage in murine lymphoma cells

(2013) Alois Strasser et al.   Mycotoxin Research

A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

(2012) Rakesh Popat et al.   BRITISH JOURNAL OF HAEMATOLOGY

Relationship Between Advanced Oxidation Protein Products, Advanced Glycation End Products, andS-Nitrosylated Proteins With Biological Risk and MDR-1 Polymorphisms in Patients Affected by B-Chronic Lymphocytic Leukemia

(2012) Sebastiano Gangemi et al.   CANCER INVESTIGATION

Changes in advanced oxidation protein products, advanced glycation end products, and s-nitrosylated proteins, in patients affected by polycythemia vera and essential thrombocythemia

(2012) Caterina Musolino et al.   CLINICAL BIOCHEMISTRY

Diphenyl diselenide attenuates hepatic and hematologic toxicity induced by chlorpyrifos acute exposure in rats

(2012) Carmine Inês Acker et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Improvement of iron-mediated oxidative DNA damage in patients with transfusion-dependent myelodysplastic syndrome by treatment with deferasirox

(2012) Shohei Kikuchi et al.   FREE RADICAL BIOLOGY AND MEDICINE

Increase of novel biomarkers for oxidative stress in patients with plasma cell disorders and in multiple myeloma patients with bone lesions

(2012) Sebastiano Gangemi et al.   INFLAMMATION RESEARCH

Non-Hodgkin lymphoma

(2012) Kate R Shankland et al.   LANCET

α-Tocopherol prevents lymphoma by improving antioxidant defence system of mice

(2012) Renu Sharma et al.   MOLECULAR BIOLOGY REPORTS

The Oral Iron Chelator Deferasirox Induces Apoptosis in Myeloid Leukemia Cells by Targeting Caspase

(2011) Jung-Lim Kim et al.   ACTA HAEMATOLOGICA

Efficacy and safety of oral deferasirox treatment in the posttransplant period for patients who have undergone allogeneic hematopoietic stem cell transplantation (alloHSCT)

(2011) Serdar Sivgin et al.   ANNALS OF HEMATOLOGY

Thioredoxin Interacting Protein: Redox Dependent and Independent Regulatory Mechanisms

(2011) Oded N. Spindel et al.   ANTIOXIDANTS & REDOX SIGNALING

Increase in serum protein carbonyl groups is associated with more advanced stage of disease in multiple myeloma patients

(2011) Caterina Musolino et al.   BIOMARKERS

Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice

(2011) Laxmidhar Das et al.   BIOSCIENCE REPORTS

Do reactive oxygen species play a role in myeloid leukemias?

(2011) P. S. Hole et al.   BLOOD

Carbonyl group serum levels are associated with CD38 expression in patients with B chronic lymphocytic leukemia

(2011) Caterina Musolino et al.   CLINICAL BIOCHEMISTRY

Molecular Karyotypes of Hodgkin and Reed-Sternberg Cells at Disease Onset Reveal Distinct Copy Number Alterations in Chemosensitive versus Refractory Hodgkin Lymphoma

(2011) M. L. Slovak et al.   CLINICAL CANCER RESEARCH

Reactive oxygen species: Are they important for haematopoiesis?

(2011) José L. Sardina et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Oxidative damage induced by chromium (VI) in rat erythrocytes: protective effect of selenium

(2011) Nejla Soudani et al.   JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY

Proteomic Approaches to Identifying Carbonylated Proteins in Brain Tissue

(2011) María Linares et al.   JOURNAL OF PROTEOME RESEARCH

Thioredoxin 1 Overexpression Extends Mainly the Earlier Part of Life Span in Mice

(2011) V. I. Perez et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Lethal iron deprivation induced by non-neutralizing antibodies targeting transferrin receptor 1 in malignant B cells

(2011) José A. Rodríguez et al.   LEUKEMIA & LYMPHOMA

Anti-carcinogenic action of ellagic acid mediated via modulation of oxidative stress regulated genes in Dalton lymphoma bearing mice

(2011) Sudha Mishra et al.   LEUKEMIA & LYMPHOMA

Expression and prognostic evaluation of oxidative stress markers in an immunohistochemical study of B-cell derived lymphomas

(2011) Anna Kaisa Pasanen et al.   LEUKEMIA & LYMPHOMA

Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells

(2011) Ignacio Bejarano et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Iron overload in MDS—pathophysiology, diagnosis, and complications

(2010) Norbert Gattermann et al.   ANNALS OF HEMATOLOGY

Effects of Iron Deprivation on Multidrug Resistance of Leukemic K562 Cells

(2010) Dingzhu Fang et al.   CHEMOTHERAPY

Oxidative stress is increased in primary and post−polycythemia vera myelofibrosis

(2010) Claudia Vener et al.   EXPERIMENTAL HEMATOLOGY

Deferasirox is a powerful NF- B inhibitor in myelodysplastic cells and in leukemia cell lines acting independently from cell iron deprivation by chelation and reactive oxygen species scavenging

(2010) E. Messa et al.   HAEMATOLOGICA

Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

(2010) H. Ghoti et al.   HAEMATOLOGICA

Targeting iron homeostasis induces cellular differentiation and synergizes with differentiating agents in acute myeloid leukemia

(2010) Celine Callens et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Does iron chelation therapy improve survival in regularly transfused lower risk MDS patients? A multicenter study by the GFM

(2010) Christian Rose et al.   LEUKEMIA RESEARCH

Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies

(2010) Mareike Kelkel et al.   MOLECULES

Melatonin as a Modulator of Apoptosis in B-Lymphoma Cells

(2009) Laura Paternoster et al.   Annals of the New York Academy of Sciences

Chelation of intracellular iron with the antifungal agent ciclopirox olamine induces cell death in leukemia and myeloma cells

(2009) Y. Eberhard et al.   BLOOD

The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1

(2009) Junko H. Ohyashiki et al.   CANCER SCIENCE

Ascorbic Acid Promotes Detoxification and Elimination of 4-Hydroxy-2(E)-nonenal in Human Monocytic THP-1 Cells

(2009) Cristobal L. Miranda et al.   CHEMICAL RESEARCH IN TOXICOLOGY

Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice

(2009) Víctor Tapias et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Melatonin exerts differential actions on X-ray radiation-induced apoptosis in normal mice splenocytes and Jurkat leukemia cells

(2009) Seong Soon Jang et al.   JOURNAL OF PINEAL RESEARCH

Study of antioxidant levels in patients with multiple myeloma

(2009) Alpana Sharma et al.   LEUKEMIA & LYMPHOMA

Cytotoxic Activity of Curcumin towards CCRF-CEM Leukemia Cells and Its Effect on DNA Damage

(2009) Yu Kong et al.   MOLECULES

Myelodysplastic Syndromes

(2009) Ayalew Tefferi et al.   NEW ENGLAND JOURNAL OF MEDICINE

Evaluation of oxidative status and depression-like responses in Brown Norway rats with acute myeloid leukemia

(2009) Monika A. Papiez et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Akt Downregulation by Flavin Oxidase–Induced ROS Generation Mediates Dose-Dependent Endothelial Cell Damage Elicited by Natural Antioxidants

(2009) Valeria Pasciu et al.   TOXICOLOGICAL SCIENCES

Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal and tumor leukocytes

(2009) Flavia Radogna et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Oxidative Stress by Targeted Agents Promotes Cytotoxicity in Hematologic Malignancies

(2008) Joya Chandra   ANTIOXIDANTS & REDOX SIGNALING

Myelodysplastic syndromes

(2008) S. D. Nimer   BLOOD

Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives

(2008) Joydeb Kumar Kundu et al.   CANCER LETTERS

Measurement of oxidative stress and antioxidant status in acute lymphoblastic leukemia patients

(2008) Vanessa Battisti et al.   CLINICAL BIOCHEMISTRY

Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom's Macroglobulinemia

(2008) A. M. Roccaro et al.   CLINICAL CANCER RESEARCH

Selective Growth Inhibition of Human Leukemia and Human Lymphoblastoid Cells by Resveratrol via Cell Cycle Arrest and Apoptosis Induction

(2008) Sau K. Lee et al.   JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY

Resveratrol directly targets COX-2 to inhibit carcinogenesis

(2008) Tatyana A. Zykova et al.   MOLECULAR CARCINOGENESIS

Resveratrol as an Inhibitor of Carcinogenesis

(2008) John M. Pezzuto   PHARMACEUTICAL BIOLOGY

Advanced lipid peroxidation end products in oxidative damage to proteins. Potential role in diseases and therapeutic prospects for the inhibitors

(2007) A Negre-Salvayre et al.   BRITISH JOURNAL OF PHARMACOLOGY